These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26841787)

  • 21. [Cardiovascular and gastrointestinal safety of NSAIDs].
    van den Bemt P; Tjwa ET; van Oijen MG
    Ned Tijdschr Geneeskd; 2014; 158():A7311. PubMed ID: 24713339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diclofenac: update on tolerableness and spinal anti-inflammatory action].
    Sandri A
    Minerva Med; 2014 Aug; 105(4):313-8. PubMed ID: 25078485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The murky waters of the coxibs: a review of the current state of play.
    Ostor AJ; Hazleman BL
    Inflammopharmacology; 2005; 13(4):371-80. PubMed ID: 16354390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
    Borer JS; Simon LS
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global safety of coxibs and NSAIDs.
    Pham K; Hirschberg R
    Curr Top Med Chem; 2005; 5(5):465-73. PubMed ID: 15974941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk of non-steroidal anti-inflammatory drugs].
    Prozzi GR; Cañás M; Urtasun MA; Buschiazzo HO; Dorati CM; Mordujovich-Buschiazzo P
    Medicina (B Aires); 2018; 78(5):349-355. PubMed ID: 30285927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.
    Amer M; Bead VR; Bathon J; Blumenthal RS; Edwards DN
    Cardiol Rev; 2010; 18(4):204-12. PubMed ID: 20539104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
    Fiorucci S
    Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment].
    Schmidt M; Fosbøl EL; Torp-Pedersen C; Olsen AS; Christensen B; Gislason GH
    Ugeskr Laeger; 2016 Dec; 178(52):. PubMed ID: 28041549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M; Burnier M
    Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to advise aspirin use in patients who need NSAIDs.
    Sopena F; Lanas A
    Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
    ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs.
    Patrono C
    Bull Mem Acad R Med Belg; 2010; 165(1-2):115-23; discussion 124. PubMed ID: 21162342
    [No Abstract]   [Full Text] [Related]  

  • 37. Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.
    Yuan JQ; Yang M; Threapleton DE; Qi XS; Ye DQ; Mao C; Tang JL; Higgins JP
    Aliment Pharmacol Ther; 2016 Oct; 44(8):785-95. PubMed ID: 27534608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The unexpected side effects of new nonsteroidal anti-inflammatory drugs.
    Uzan A
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):687-8. PubMed ID: 16262557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations.
    Pellicano R
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):255-61. PubMed ID: 25384803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.